{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T07:20:22Z","timestamp":1770967222132,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[1996,1,1]],"date-time":"1996-01-01T00:00:00Z","timestamp":820454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T00:00:00Z","timestamp":1578528000000},"content-version":"vor","delay-in-days":8774,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1996]]},"DOI":"10.1093\/annonc\/7.suppl_6.s35","type":"journal-article","created":{"date-parts":[[2012,4,5]],"date-time":"2012-04-05T22:52:07Z","timestamp":1333666327000},"page":"S35-S39","source":"Crossref","is-referenced-by-count":22,"special_numbering":"S6","title":["Mantle-cell lymphoma: Classification and therapeutic implications"],"prefix":"10.1016","volume":"7","author":[{"given":"R.I.","family":"Fisher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0005","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2","article-title":"National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas. Summary and description of a working formulation for clinical usage","volume":"49","author":"The Non-Hodgkin's Lymphoma Pathologic Classification Project","year":"1982","journal-title":"Cancer"},{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0010","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0308-2261(74)80005-6","article-title":"Histopathology of malignant lymphomas","volume":"3","author":"Berard","year":"1974","journal-title":"Clin Haematol"},{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0015","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/1097-0142(19810915)48:6<1415::AID-CNCR2820480625>3.0.CO;2-N","article-title":"Malignant lymphoma, intermediate lymphocytic type: A clinicopathologic study of 42 cases","volume":"48","author":"Weisenburger","year":"1981","journal-title":"Cancer"},{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0020","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2141.1975.tb00911.x","article-title":"The histopathology of malignant lymphoma","volume":"31","author":"Lennert","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0025","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00000478-199207000-00001","article-title":"Mantle cell lymphoma: A proposal for unification of morphologic, immunologic, and molecular data","volume":"16","author":"Banks","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0030","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American Classification of lymphoid neoplasm: A proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0035","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/1097-0142(19820401)49:7<1429::AID-CNCR2820490720>3.0.CO;2-5","article-title":"Mantle-zone lymphoma: A follicular variant of intermediate lymphocytic lymphoma","volume":"49","author":"Weisenburger","year":"1982","journal-title":"Cancer"},{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0040","first-page":"181","article-title":"Centrocytic lymphoma: A distinct clinicopathologic and immunologic entity: A multiparameter study of 18 cases at diagnosis and relapse","volume":"113","author":"Swerdlow","year":"1983","journal-title":"Am J Pathol"},{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0045","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1182\/blood.V85.4.1075.bloodjournal8541075","article-title":"A clinical analysis of two indolent lymphoma entities: Mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): A Southwest Oncology Group Study","volume":"85","author":"Fisher","year":"1995","journal-title":"Blood"},{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0050","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/oxfordjournals.annonc.a058904","article-title":"European Lymphoma Task Force (ETLF): Report of the workshop on mantle cell lymphoma (MCL)","volume":"5","author":"Zucca","year":"1994","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0055","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/oxfordjournals.annonc.a059164","article-title":"Mantle cell lymphoma: A new lymphoproliferative entity with definite histopathological patterns, clinical characteristics and prognostic factors, and an investigational therapeutic approach","volume":"6","author":"Garcia-Conde","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0060","first-page":"388a","article-title":"Three histological variants of mantle cell lymphoma (MCL) exhibit striking heterogeneity in clinical behavior and biological features","volume":"82","author":"Majilis","year":"1993","journal-title":"Blood"},{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0065","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/1097-0142(19900801)66:3<522::AID-CNCR2820660320>3.0.CO;2-4","article-title":"Mantle zone lymphoma: A clinicopathologic study of 22 cases","volume":"66","author":"Duggan","year":"1990","journal-title":"Cancer"},{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0070","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1182\/blood.V78.2.259.bloodjournal782259","article-title":"Bcl-1, t(ll;14), and mantle cell lymphoma","volume":"78","author":"Raffeld","year":"1991","journal-title":"Blood"},{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0075","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1200\/JCO.1993.11.4.802","article-title":"Intermediate lymphcytic lymphoma: Clinical and pathologic features of a recently characterized subtype of non-Hodgkin's lymphoma","volume":"11","author":"Shivdasani","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0080","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1182\/blood.V83.6.1626.1626","article-title":"Antigen expression and polymerase chain reaction amplification of mantle cell lymphomas","volume":"83","author":"Molot","year":"1994","journal-title":"Blood"},{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0085","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1182\/blood.V69.6.1617.1617","article-title":"Intermediate lymphocytic lymphoma: Immunophenotypic and cytogenetic findings","volume":"69","author":"Weisenburger","year":"1987","journal-title":"Blood"},{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0090","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2141.1991.tb08582.x","article-title":"Non-Hodgkin's lymphomas with t(ll;14)(ql3;q32): A subset of mantle zone\/intermediate lymphocytic lymphoma?","volume":"77","author":"Leroux","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0095","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/path.1711630104","article-title":"Translocation (11;14): A cytogenetic anomaly associated with B-cell lymphomas of non-follicle centre cell lineage","volume":"163","author":"Vandenberghe","year":"1991","journal-title":"J Pathol"},{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0100","doi-asserted-by":"crossref","first-page":"9638","DOI":"10.1073\/pnas.88.21.9638","article-title":"Overexpression of PRAD1, a candidate BCL-1 breakpoint region oncogene, in centrocytic lymphomas","volume":"88","author":"Rosenberg","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0105","first-page":"86","article-title":"BCL-1 (Cyclin Dl) protein expression in low grade B-cell lymphomas and reactive hyperplasia","volume":"145","author":"Yang","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0110","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1182\/blood.V86.7.2715.2715","article-title":"Cyclin Dl protein analysis in the diagnosis of mantle cell lymphoma","volume":"86","author":"de Boer","year":"1995","journal-title":"Blood"},{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0115","first-page":"117a","article-title":"Identification of nuclear and cytoplasmic forms of cyclin Dl using monoclonal antibodies","volume":"82","author":"Wroblewski","year":"1993","journal-title":"Blood"},{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0120","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1182\/blood.V83.7.1871.1871","article-title":"Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas","volume":"83","author":"Rimokh","year":"1994","journal-title":"Blood"},{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0125","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1200\/JCO.1993.11.4.644","article-title":"Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmmunotherapy","volume":"11","author":"Dana","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0130","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1200\/JCO.1995.13.11.2819","article-title":"Efficacy of four different regimens in 64 mantle-cell lymphoma cases: Clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes","volume":"13","author":"Teodorovic","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0135","first-page":"3","article-title":"Evaluation and management of mantle cell lymphoma","volume":"6","author":"Press","year":"1996","journal-title":"Adv Leuk Lymph"},{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0140","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/oxfordjournals.annonc.a059154","article-title":"Mantle cell lymphoma: Natural history defined in a serially biopsied population over a 20-year period","volume":"6","author":"Norton","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0145","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/hon.2900070505","article-title":"Multicentre randomized therapeutic trial for advanced centrocytic lymphoma: Anthracycline does not improve the prognosis","volume":"7","author":"Meusers","year":"1989","journal-title":"Hematol Oncol"},{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0150","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/oxfordjournals.annonc.a059155","article-title":"Patterns of survival in mande cell lymphoma","volume":"6","author":"Zucca","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0155","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1002\/1097-0142(19850501)55:9<1948::AID-CNCR2820550920>3.0.CO;2-K","article-title":"Malignant lymphoma presenting with prominent splenomegaly: A clinicopathogic study with special reference to intermediate lymphoma","volume":"55","author":"Narang","year":"1985","journal-title":"Cancer"},{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0160","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2559.1995.tb00615.x","article-title":"Mantle cell lymphoma: A clinicopathological study of 55 cases","volume":"26","author":"Pittaluga","year":"1995","journal-title":"Histopathology"},{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0165","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1182\/blood.V83.10.2829.2829","article-title":"Nonfollicular small B-cell lymphomas: A heterogeneous group of patients with distinct clinical features and outcome","volume":"83","author":"Berger","year":"1994","journal-title":"Blood"},{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0170","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/oxfordjournals.annonc.a059148","article-title":"Mantle cell lymphoma: A therapeutic dilemma","volume":"6","author":"Coiffier","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0175","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/oxfordjournals.annonc.a059156","article-title":"The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma","volume":"6","author":"Stewart","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0180","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin's lymphoma","volume":"329","author":"The International Non-Hodgkin's Lymphoma Prognostic Factors Project","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0185","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/jnci\/82.9.742","article-title":"Lymphocytic lymphoma of intermediate differentiation: Morphologic, immunophenotypic, and prognostic factors","volume":"82","author":"Bookman","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/7.suppl_6.S35_bb0190","first-page":"1057","article-title":"Combination chemotherapy in non-Hodgkin's lymphoma: Results of long-term follow-up","volume":"61","author":"Anderson","year":"1977","journal-title":"Cancer Treat Rep"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753420305512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753420305512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/7\/suppl_6\/S35\/6680267\/7-suppl_6-S35.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T16:11:57Z","timestamp":1589472717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753420305512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996]]},"references-count":38,"alternative-id":["S0923753420305512"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/7.suppl_6.s35","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1996]]}}}